Table 2 Clinical characteristics of the patients (all male) with aortic stenosis.
From: Skeletal muscle derived Musclin protects the heart during pathological overload
Aortic stenosis N = 26 | Normal values | Healthy N = 56 | |
|---|---|---|---|
Age (years) | 79.4 ± 7.7**** | 60.5 ± 4.3 | |
BMI (g/m2) | 25.9 ± 3.1 | 18.5–25 | |
Diabetes mellitus (n) | 8 | 0 | |
Echocardiography | |||
Ejection fraction (%) | 45.7 ± 15.9 (n = 17) | >55 | |
Septum thickness (mm) | 14.5 ± 0.5 (n = 25) | ≤11 | |
Left ventricular enddiastolic diameter (mm) | 48.9 ± 6 (n = 25) | 42–58 | |
Aortic valve gradient, mean (mmHg) | 37.4 ± 16.1 | ≤20 | |
Aortic valve area (cm2) | 0.7 ± 0.18 | >1.5 | |
Serum | |||
Musclin (ng/ml) | 2.36 ± 1* | 3.38 ± 2.3 | |
Creatinine (µmol/l) | 124.5 ± 58 | 59–104 | |
Clinical classification [% of all patients] | |||
NYHA I | 15.4 | ||
NYHA II | 23.1 | ||
NYHA III | 46.2 | ||
NYHA IV | 15.4 | ||
Medication [% of all patients] | |||
ACE inhibitor | 50 | ||
Angiotensin receptor antagonist | 19.2 | ||
β-receptor antagonist | 69.2 | ||
Diuretic | 69.2 | ||
Calcium channel antagonist | 38.5 | ||